Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Recombinant Human Oncostatin M: Optimizing Fibroblast Assays
2026-05-14
Leverage Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) for advanced, reproducible cell-based assays. Discover protocol enhancements and troubleshooting strategies that directly translate recent mitochondrial quality insights into fibroblast proliferation workflows.
-
Haloprogin: Translational Leverage in Antifungal Research
2026-05-14
This article dissects the biological mechanisms, experimental paradigms, and strategic translational opportunities surrounding Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene). Integrating landmark literature, competitive insights, and practical protocol guidance, it empowers researchers to harness Haloprogin for advanced dermatophyte, Candida, and Gram-positive infection models. With a focus on evidence-driven optimization and clinical relevance, this perspective positions Haloprogin as a next-generation tool for bridging preclinical and translational mycology.
-
Annexin-V Detection of Cardiomyocyte Death in Murine I/R Inj
2026-05-13
This study demonstrates the use of labeled recombinant annexin-V as a precise in situ marker for early and late cardiomyocyte death in a mouse model of myocardial ischemia/reperfusion (I/R) injury. The findings refine our understanding of the temporal dynamics of cell death after I/R and offer a sensitive platform for evaluating cell death–blocking therapies.
-
Astrocytic GAT-3 Controls Synaptic Transmission and Memory i
2026-05-13
This study uncovers how astrocytic GAT-3 regulates synaptic transmission and contextual memory formation in the dentate gyrus. By integrating advanced electrophysiology, optogenetics, and behavioral assays, the authors demonstrate a critical astrocyte-mediated mechanism for GABAergic modulation of excitatory circuits with implications for cognitive function and disease.
-
P2RX1 Drives Mitochondrial Apoptosis via CaMKII/PI3K-Akt Sup
2026-05-12
Li et al. (2025) reveal that P2RX1 overexpression sensitizes Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells to mitochondrial apoptosis by disrupting calcium homeostasis and suppressing PI3K/Akt signaling. These mechanistic insights highlight P2RX1 as a potential therapeutic target and inform advanced apoptosis detection assay strategies.
-
E-64d: Advanced Strategies for Cysteine Protease Inhibition
2026-05-12
Explore how E-64d enables precise cysteine protease inhibition in living cells, with a deep dive into calpain-targeted research and unique protocol insights. Uncover advanced applications, mechanistic clarity, and practical assay guidance for scientists using E-64d.
-
Cyanine 5-dCTP: High-Fidelity DNA Fluorescent Probe Synthesi
2026-05-11
Cyanine 5-dCTP empowers researchers to achieve robust, high-sensitivity fluorescent DNA labeling for advanced molecular workflows. Its compatibility with enzymatic oligonucleotide synthesis and next-generation DNA frameworks delivers reproducible, high-yield results for nucleic acid detection and fluorescence microscopy.
-
Olaparib (AZD2281): Mechanisms and Limits in DNA Repair Rese
2026-05-11
Olaparib (AZD2281) is a selective PARP-1/2 inhibitor used to interrogate DNA repair mechanisms, especially in BRCA-deficient contexts. APExBIO's Olaparib enables precise DNA damage response assays and tumor radiosensitization studies. Its mechanistic selectivity and experimental parameters are benchmarked by recent molecular cell biology research.
-
Disrupting SARS-CoV-2 Nucleocapsid Phase Separation: GCG as
2026-05-10
This study reveals that the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process essential for viral replication. The authors demonstrate that (-)-gallocatechin gallate (GCG) disrupts this LLPS, significantly inhibiting viral replication—a finding with profound implications for antiviral strategy development.
-
GA-Driven Autophagic Degradation of DELLA Proteins in Arabid
2026-05-09
This study uncovers a novel autophagy pathway in which gibberellin (GA) triggers ATG8-dependent autophagic degradation of DELLA proteins, promoting seed germination and skotomorphogenesis under nutrient starvation in Arabidopsis. These findings reveal a previously uncharacterized mechanism connecting hormonal signaling and protein homeostasis during early plant development.
-
Acridine Orange hydrochloride: Practical Guide for Cytochemi
2026-05-08
Acridine Orange hydrochloride offers researchers a reliable, dual-fluorescence approach for differential DNA and RNA staining in flow cytofluorometric and cytochemical workflows. This product is best suited for cell cycle analysis, apoptosis detection, and nucleic acid-specific assays, but should not be applied to long-term solution storage or non-nucleic acid targets due to stability limits. Use is recommended where high purity, spectral separation, and reproducible QC are critical.
-
E-64 and Lysoptosis: Precision Tools for Translational Resea
2026-05-08
Explore how E-64, a potent L-trans-epoxysuccinyl peptide, empowers translational researchers to dissect and manipulate lysosomal cell death pathways. This article bridges mechanistic insight from landmark lysoptosis studies with strategic guidance for experimental design, highlighting E-64’s competitive advantages and practical parameters for reliable cysteine protease inhibition.
-
Oridonin Inhibits Esophageal Cancer by Modulating Inflammati
2026-05-07
Peng et al. (2025) provide direct evidence that oridonin suppresses esophageal cancer progression by inhibiting the TLR4/NF-κB/NLRP3 inflammasome pathway. Their findings clarify the mechanistic link between chronic inflammation and esophageal carcinogenesis, informing anti-cancer strategies focused on selective inflammation modulation.
-
P2Y11 Antagonist NF 340: Precision Tool for GPCR Signaling S
2026-05-07
NF 340 stands out as a highly selective P2Y11 antagonist, empowering researchers to dissect purinergic GPCR signaling with reproducibility and specificity. Unlock robust experimental workflows in cancer, immunology, and inflammation pathway modulation with enhanced troubleshooting guidance and direct translation from recent peer-reviewed breakthroughs.
-
Bardoxolone Methyl: Advanced Redox Modulation in Applied Res
2026-05-06
Bardoxolone methyl (CDDO methyl ester) stands out as a potent and versatile modulator of Nrf2 and NF-kB signaling, enabling researchers to dissect oxidative stress and inflammation with precision. Recent advances leveraging redox pathway insights, including combinatorial strategies in cancer and kidney models, place Bardoxolone methyl at the frontier of applied redox biology.